Brian C. Stephenson, Secretary, Treasurer & CFO at BridgeBio Pharma, Inc. (BBIO), sold 129,858 shares at $14.18 ($1.8M) on 2023-05-03, disclosed to the SEC on 2023-05-05.
Scheduled sale ($1.8M) by Secretary, Treasurer & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.18 | 64,929 | $921K | 50.0% |
| 2 | $14.18 | 64,929 | $921K | 50.0% |
| Total | $14.18 avg | 129,858 | $1.8M | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |